Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,452,620
-$1,376,829 QoQ
Shares Held
42,192
-36.0% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWINBEECH CAPITAL LP holds $20,335,714 across 18 Biotechnology names. PCVX ranks #3 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
18,135 | $4,438,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,325 | $4,312,254 | |
| 3 | PCVX |
Vaxcyte, Inc.
This page
|
42,192 | $2,452,620 | |
| 4 | INSM |
INSMED Inc
|
13,646 | $1,454,936 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
31,387 | $1,214,676 | |
| 6 | TWST |
Twist Bioscience Corp
|
9,600 | $987,648 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
9,900 | $737,352 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
16,200 | $695,142 |
All Filings in PCVX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,452,620 | 42,192 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,829,449 | 65,900 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,609,947 | 78,239 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,215,693 | 228,087 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,360,592 | 503,248 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,291,478 | 404,965 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $22,916,215 | 279,944 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $2,161,806 | 31,647 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||